Valuation: Caplin Point Laboratories Limited

Market Cap 200B 2.08B 1.85B 1.73B 1.57B 2.96B 3B 20.88B 8.08B 102B 7.8B 7.63B 327B P/E 2027 *
27.5x
P/E 2028 * 23.8x
Enterprise Value 200B 2.08B 1.85B 1.73B 1.57B 2.96B 3B 20.88B 8.08B 102B 7.8B 7.63B 327B EV / Sales 2027 *
7.98x
EV / Sales 2028 * 7.06x
Free-Float
26.56%
Yield 2027 *
0.15%
Yield 2028 * 0.15%
1 day-3.11%
1 week-8.21%
Current month-3.11%
1 month-2.92%
3 months+2.65%
6 months+67.63%
Current year+43.19%
1 week 2,540
Extreme 2540
2,869.8
1 month 2,490.5
Extreme 2490.5
2,990
Current year 1,500.3
Extreme 1500.3
2,990
1 year 1,500.3
Extreme 1500.3
2,990
3 years 954
Extreme 954
2,990
5 years 575
Extreme 575
2,990
10 years 176.2
Extreme 176.2
2,990
Manager TitleAgeSince
Chief Executive Officer 71 2015-03-27
Director of Finance/CFO - 2016-02-18
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 2010-01-26
Director/Board Member - 2025-11-04
Director/Board Member 71 2015-03-27
Change 5-day change 1-year change 3-year change Capi.($)
-3.11%-8.21% - - 2.15B
-0.62%-2.71%+39.30%+114.07% 1,031B
-2.30%-4.44%+39.03%+66.07% 638B
-0.63%-1.96%+6.36%+74.38% 462B
-1.03%-2.82%+59.56%+39.69% 359B
-0.03%-3.96%+23.63%+39.35% 335B
-1.58%-0.76%+13.50%+25.77% 273B
-2.02%-2.97%-3.25%+8.38% 253B
-3.38%+0.30%+36.44%+51.54% 228B
-1.04%-1.46%+32.70%+96.82% 185B
Average -1.58%-1.58%+27.47%+57.34% 418.21B
Weighted average by Cap. -1.25%-1.89%+30.52%+69.18%

Financials

2027 *2028 *
Net sales 25.07B 260M 231M 216M 197M 371M 376M 2.62B 1.01B 12.77B 978M 957M 41.01B 28.34B 294M 261M 244M 223M 419M 425M 2.96B 1.14B 14.43B 1.11B 1.08B 46.36B
Net income 7.26B 75.45M 67.02M 62.67M 57.11M 108M 109M 758M 293M 3.7B 283M 277M 11.88B 8.41B 87.36M 77.59M 72.56M 66.12M 124M 126M 878M 340M 4.28B 328M 321M 13.76B
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
4,199
Date Price Change Volume
26-10-01 ₹2,631.90 -3.11% 154,382
26-09-30 ₹2,716.40 -1.01% 156,298
26-09-29 ₹2,744.00 -3.85% 93,586
26-09-28 ₹2,854.00 +0.67% 121,333
26-09-25 ₹2,835.10 -1.13% 181,149
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,632.35INR
Average target price
2,765.00INR
Spread / Average Target
+5.04%

Quarterly revenue - Rate of surprise